Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Commensal Propionibacterium strain UF1 mitigates intestinal inflammation via Th17 cell regulation
Natacha Colliou, … , Shuzhao Li, Mansour Mohamadzadeh
Natacha Colliou, … , Shuzhao Li, Mansour Mohamadzadeh
Published September 25, 2017
Citation Information: J Clin Invest. 2017;127(11):3970-3986. https://doi.org/10.1172/JCI95376.
View: Text | PDF
Research Article Immunology Inflammation

Commensal Propionibacterium strain UF1 mitigates intestinal inflammation via Th17 cell regulation

  • Text
  • PDF
Abstract

Consumption of human breast milk (HBM) attenuates the incidence of necrotizing enterocolitis (NEC), which remains a leading and intractable cause of mortality in preterm infants. Here, we report that this diminution correlates with alterations in the gut microbiota, particularly enrichment of Propionibacterium species. Transfaunation of microbiota from HBM-fed preterm infants or a newly identified and cultured Propionibacterium strain, P. UF1, to germfree mice conferred protection against pathogen infection and correlated with profound increases in intestinal Th17 cells. The induction of Th17 cells was dependent on bacterial dihydrolipoamide acetyltransferase (DlaT), a major protein expressed on the P. UF1 surface layer (S-layer). Binding of P. UF1 to its cognate receptor, SIGNR1, on dendritic cells resulted in the regulation of intestinal phagocytes. Importantly, transfer of P. UF1 profoundly mitigated induced NEC-like injury in neonatal mice. Together, these results mechanistically elucidate the protective effects of HBM and P. UF1–induced immunoregulation, which safeguard against proinflammatory diseases, including NEC.

Authors

Natacha Colliou, Yong Ge, Bikash Sahay, Minghao Gong, Mojgan Zadeh, Jennifer L. Owen, Josef Neu, William G. Farmerie, Francis Alonzo III, Ken Liu, Dean P. Jones, Shuzhao Li, Mansour Mohamadzadeh

×

Figure 2

Characterization of P. UF1 bacterium.

Options: View larger image (or click on image) Download as PowerPoint
Characterization of P. UF1 bacterium.
(A) Genome sequence comparison of ...
(A) Genome sequence comparison of isolated P. UF1 with known P. freudenreichii spp. Shermanii CIRM-BIA1 (red) and P. freudenreichii spp. freudenreichii DSM20271T (blue). Prophage was identified by PHAST (green). Sequence identity between P. freudenreichii strains and P. UF1 is shown. (B) Correlation of the annotated genome sequence on the RAST platform with different metabolic pathways of P. UF1. Numbers in parentheses indicate numbers of annotated genes belonging to subcategories of pathways. (C and D) C57BL/6 mice (n = 3) were gavaged with P. UF1 (109 CFU/mouse) 1 time, and mice were sacrificed every day to detect P. UF1 in the fecal (C) and cecal (D) contents. (E) GF mice (n = 5) were gavaged with P. UF1 (109 CFU/mouse) 1 time, and fecal samples were collected every day to detect P. UF1. DL indicates the qPCR detection limit. Asterisks indicate statistical significance compared with day 0. Data are representative of 1 (E) or 3 (C and D) independent experiments. Error bars indicate mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, 2-tailed unpaired t test (C–E).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts